| Unique ID issued by UMIN | UMIN000057768 |
|---|---|
| Receipt number | R000065750 |
| Scientific Title | Transcatheter versus conservative strategies for severe mitral regurgitation requiring Impella support |
| Date of disclosure of the study information | 2025/05/03 |
| Last modified on | 2026/09/03 14:34:25 |
The Transcatheter strategy for severe mitral regurgitation requiring percutaneous ventricular assist device support study
TREAT MR study
Transcatheter versus conservative strategies for severe mitral regurgitation requiring Impella support
Treatment strategies with Impella for MR
| Japan |
Isolated severe MR complicated by either drug-refractory heart failure or cardiogenic shock requiring Impella support
| Cardiology |
Others
NO
This study sought to evaluate the short-term clinical outcomes of transcatheter strategy for severe MR requiring Impella support for hemodynamic stabilization, using a nationwide registry of all Impella-treated patients in Japan.
Safety,Efficacy
The primary outcome was in-hospital mortality.
Secondary outcomes were in-hospital events, including cardiac death, stroke, cardiac tamponade, acute kidney injury, sepsis, severe bleeding, limb ischemia, and ventricular tachycardia or fibrillation.
Observational
| Not applicable |
| Not applicable |
Male and Female
Patients with severe MR complicated by drug-refractory heart failure or cardiogenic shock requiring Impella support
Patients who required therapeutic interventions other than for the mitral valve
100
| 1st name | Tsuyoshi |
| Middle name | |
| Last name | Isawa |
Sendai Kousei Hospital
Cardiology Department
981-0914
1-20, Tsutsumidouri-amamiya, Sendai, Japan
022-728-8000
isa_tsuyo@yahoo.co.jp
| 1st name | Tsuyoshi |
| Middle name | |
| Last name | Isawa |
Sendai Kousei Hospital
Cardiology Department
981-0914
1-20, Tsutsumidouri-amamiya, Sendai, Japan
022-728-8000
isa_tsuyo@yahoo.co.jp
Sendai Kousei Hospital
None
Self funding
Sendai Kousei Hospital
1-20, Tsutsumidouri-amamiya, Sendai, Japan
0227288000
isa.tsuyo@gmail.com
NO
| 2025 | Year | 05 | Month | 03 | Day |
https://www.jstage.jst.go.jp/article/circrep/advpub/0/advpub_CR-26-0155/_html/-char/en
Published
https://www.jstage.jst.go.jp/article/circrep/advpub/0/advpub_CR-26-0155/_html/-char/en
82
The in-hospital mortality rate was 29% (5/17) and 69% (11/16), respectively. In the unadjusted analyses, the transcatheter strategy was associated with a lower risk of in-hospital death (HR: 0.18, 95% confidence interval [CI]: 0.05-0.58, P=0.004) . After overlap weighting, the transcatheter strategy remained associated with a lower risk of in-hospital death compared with the conservative strategy (HR: 0.13, 95% CI: 0.03-0.52, P=0.004).
| 2026 | Year | 09 | Month | 03 | Day |
Patients with severe MR and advanced chronic heart failure who required Impella support for hemodynamic stabilization between February 2020 and December 2023 were included. Patients undergoing major concomitant cardiac interventions or those receiving Impella as a bridge to surgical correction of acute MR were excluded. Patients were managed either with a transcatheter strategy, defined as M-TEER using the MitraClip system (Abbott; Menlo Park, CA, USA) during Impella support, or with a conservative strategy comprising Impella support and intensive medical therapy without mitral valve intervention.
Patients with severe MR and advanced chronic heart failure who required Impella support for hemodynamic stabilization between February 2020 and December 2023 were included. Patients undergoing major concomitant cardiac interventions or those receiving Impella as a bridge to surgical correction of acute MR were excluded. Patients were managed either with a transcatheter strategy, defined as M-TEER using the MitraClip system (Abbott; Menlo Park, CA, USA) during Impella support, or with a conservative strategy comprising Impella support and intensive medical therapy without mitral valve intervention.
There was no significant difference in adverse events between the two groups.
The primary outcome was inhospital death.
Main results already published
| 2020 | Year | 02 | Month | 01 | Day |
| 2025 | Year | 01 | Month | 20 | Day |
| 2020 | Year | 02 | Month | 01 | Day |
| 2025 | Year | 02 | Month | 01 | Day |
Retrospective cohort study
| 2025 | Year | 05 | Month | 03 | Day |
| 2026 | Year | 09 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065750